iv bag
Potassium Phosphate /  Sodium phosphate
The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgement. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.    PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents
NS, D5W

Standard Dilutions   [Amount of drug] [Infusion volume] [Infusion rate]
Floors:
[15 mmol] [250 ml] [4-6 hours]

ICU's:
[15 mmol] [100 ml] [2 hours]

Stability / Miscellaneous
EXP: 1 DAY (RT).

Potassium Phosphate
[Supplied: 15 mmol PO4 (and 22 meq K+) / 5 ml vial].

Sodium Phosphate
[Supplied: 15 mmol PO4 (and 20 meq Na+) / 5 ml vial].

Normal range: 2.5 to 4.5 mg/dl.

Dosing:
*Mild to moderate hypophosphatemia (1.3 to 2.5 mg/dl): Oral therapy adequate: 2.5 to 5 mg/kg of PO4 bid-tid or approximately 1-2 pkts (250 mg=8 mmol/packet) of Neutra-phos bid to tid.
Manufacturer recommends: 1-2 packets 4 times daily (after meals and at bedtime)

*Severe hypophosphatemia (PO4 < 1.2 mg/dl): Give 0.16 to 0.25 mmol/kg IVPB q6 to 8 hours until serum level reaches 2 mg/dl.

Doses as high as 0.5 mmol/kg may be given if level is below 0.7 mg/dl.

*Alternatively: (level < 2 mg/dl) (ICU patient): give 15 mmol NaPO4 in 100 ml NS over 2 to 6 hrs; repeat q6h to max of 45 mmol/24 hours. [Crit Care Med 1995;23:1204.]

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgement. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.    PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.